Table 2 Laboratory findings of patients with COVID-19.
From: Moderate vs. mild cases of overseas-imported COVID-19 in Beijing: a retrospective cohort study
Laboratory findings | Reference range | Mild (nā=ā21) | Moderate (nā=ā32) | p |
|---|---|---|---|---|
Blood cell count | ||||
White blood cell count,āĆā109/L | 3.5ā9.5 | 5.1[4.05ā5.2] | 5.2[3.82ā6.25] | 0.894a |
Neutrophil count,āĆā109/L | 1.8ā6.3 | 2.11[1.69ā3.23] | 3.12[1.88ā4.33] | 0.068a |
Neutrophil percentage, % | 40ā75 | 43.9[37.8ā54.2] | 57.3[48.25ā64.7] | ā<ā0.001a |
Lymphocyte count,āĆā109/L | 1.1ā3.2 | 2.25[1.62ā2.85] | 1.65[1.21ā2.10] | 0.010a |
Lymphocyte percentage, % | 20ā50 | 44.0[35.8ā50.05] | 33.5[28.7ā41.3] | 0.003a |
NLR | Ā | 0.96[0.72ā1.47] | 1.74[1.19ā2.18] | ā<ā0.001a |
Haemoglobin, g/L | 130ā175 | 134[127.5ā141.5] | 142.0[123.5ā148.5] | 0.467a |
Platelet count,āĆā109/L | 125ā350 | 210[191.5ā247.0] | 195.0[171.0ā268] | 0.743a |
Blood biochemistry | ||||
Albumin, g/L | 40ā50 | 44.4[43.25ā46.55] | 43.15[41.52ā44.97] | 0.072a |
ALT, U/L | 9ā50 | 14.2[10.5ā20.45] | 18.1[6.51ā12.75] | 0.029a |
AST, U/L | 15ā40 | 18.6[15.5ā20.85] | 20.5[17.2ā24.85] | 0.256a |
Total bilirubin, mmol/L | 1.7ā23 | 10.13[6.84ā12.28] | 8.88[6.56ā12.75] | 0.611a |
Potassium, mmol/L | 3.5ā5.3 | 4.20[4.12ā4.72] | 4.47[4.13ā4.95] | 0.317a |
Sodium, mmol/L | 137ā147 | 139.6[138.25ā141.55] | 139.45[137.92ā141.45] | 0.849a |
Creatinine, μmol/L | 57ā97 | 59.2[54.15ā66.45] | 67.7[58.67ā91.27] | 0.033a |
LDH, U/L | 120ā250 | 163.30[143.25ā199.15] | 181.05[149.85ā212.00] | 0.252a |
cTnI, pg/mL | 0ā40 | 0.1[0.1ā0.1] | 0.1[0.1ā0.1] | 0.418a |
CKMB, U/L | 0ā25 | 8.8[8.0ā12.1] | 10.3[8.125ā14.475] | 0.287a |
Triglyceride, mmol/L | 0.6ā1.7 | 0.68[0.54ā1.01] | 0.88[0.776ā1.02] | 0.052a |
HDL, mmol/L | 1.04ā1.56 | 2.19[1.73ā2.83] | 1.45[1.13ā2.42] | 0.008a |
LDL, mmol/L | 1.03ā3.38 | 2.21[1.65ā2.42] | 2.19[1.73ā2.83] | 0.335a |
Total cholesterol, mmol/L | 3.1ā5.2 | 3.94[3.45ā4.42] | 3.80[3.25ā4.61] | 0.920a |
Glucose, mmol/L | 3.9ā6.1 | 4.93[4.57ā5.10] | 4.92[4.72ā5.19] | 0.518a |
Lactic acid, mmol/L | 0ā2 | 2.1[1.8ā2.3] | 2.1[1.7ā2.4] | 0.802a |
Coagulation | ||||
PT, s | 9.1ā12.1 | 13.6[13.35ā14.15] | 13.6[13.12ā14.00] | 0.964a |
APTT, s | 25.4ā38.4 | 39.8[35.5ā42.55] | 39.15[37.00ā45.22] | 0.418a |
Fibrinogen, mg/dL | 2ā4 | 2.62[2.495ā3.015] | 3.48[2.88ā3.87] | ā<ā0.001a |
D-dimer, mg/L | 0ā231 | 220[220ā300] | 270[220ā402.5] | 0.127a |
Infection-related | ||||
PCT, ng/mL | 0.02ā0.5 | 0.03[0.03ā0.375] | 0.04[0.03ā0.067] | 0.007a |
CRP, mg/L | 0ā6 | 0.39[0.165ā1.335] | 3.41[0.865ā17.24] | 0.010a |
ESR, mm/h | 0ā15 | 7.0[4.0ā10.5] | 14.0[7.25ā24.5] | 0.001a |
Radiologic findings | ||||
GGO | Ā | Ā | 28(87.5) | Ā |
Consolidation | Ā | Ā | 14(43.8) | Ā |
Lesion distribution | ||||
Ā Local | Ā | Ā | 17(53.1) | Ā |
Ā Multifocal | Ā | Ā | 15(46.9) | Ā |
Ā Unilateral | Ā | Ā | 22(68.8) | Ā |
Ā Bilateral | Ā | Ā | 10(31.3) | Ā |
Total CT score | Ā | Ā | 2[1ā3] | Ā |